Tom Hale’s Post

👀 💍🩷 I’ve been accessorising my OURA ring with a large pair of rose-tinted spectacles since it allowed me to analyse my cycle across multiple biometrics, so please allow me to indulge in this fangirl moment. So many brands talk about having a vision for the future but few are accelerating and executing with the finesse of ŌURA. I’ve picked out the signals in Tom Hale’s post which have my synapses firing: 💫 *Metabolic Health Offering* - The future of health will rely on moving away from the use of “moment in time” singular biometrics to create “personalised nutrition/ lifestyle plans” (sorry Zoe I’m looking at you) and move towards a suite of offers which rely on multiple biometrics updated in real time. ☄️*Co-market and Cross-sell, Combined Product Experience* - The future of health involves a product experience which puts the patient at the core, connecting data across their HCPs and social platforms, wearables and diagnostics, homes and hospitals. When I can’t sleep at night I imagine the partnerships that could really create impact for women if they were to do exactly this (available in my DMs for anyone who wants to add their dream partnerships to the wish list). 🤌🏻 *Deeper, More Personalised Insights* - Each generation is more diverse than the last, and as a result the chance of your super generalised advice applying to the “majority” is getting even slimmer. Future-proofing means meeting the needs of the individual, overcoming gaps in culturally competent care and incomplete data sets. Any winning strategy in the future will need to go deep and get personal with the “marginalised masses”. *Oh and it goes unsaid all of the above needs to be delivered alongside a data security strategy and trust building comms, or the future isn’t yours at all ⛓️💥

Continuous glucose monitoring is making steady progress to become a mainstream biomarker.

Two important reflections here that may portend the future for DHT -the need for software platforms that can house and integrate data from different sensors -the expected demand from consumers for multi-parameter sensing

🌟 Exciting News in Health Tech! 🌟 Following the announcement of the strategic partnership between Dexcom a leader in continuous glucose monitoring technology, and ŌURA the innovative sleep and wellness tracker. This collaboration aims to enhance diabetes management by integrating Dexcom’s CGM data with ŌURA’s advanced health metrics. 🔗 This partnership will empower users to make more informed health decisions by combining glucose monitoring with insights on sleep, readiness, and overall wellbeing. Imagine the potential of having real-time glucose data alongside sleep quality and activity levels at your fingertips! 💡 Key Highlights: - Enhanced User Experience: Integration of data will provide users with a comprehensive view of their health. - Empowering Individuals: This collaboration is about putting the power of data into the hands of users to help them manage their metabolic health more effectively. - Innovative Health Solutions: Together, Dexcom and ŌURA are paving the way for future advancements in personalized health technology. As we continue to navigate the evolving landscape of health tech, partnerships like this remind us of the transformative potential of data-driven solutions in improving health outcomes and the importance of brilliant legal teams behind them to make it possible. #HealthTech #DiabetesManagement #Data #Wellness #Innovation #Dexcom #ŌURA #Partnership https://lnkd.in/edWi7vW8

Dexcom partners with Oura, invests $75M in ring maker - MobiHealthNews Exciting news in the healthcare tech space! Dexcom has made a strategic $75 million investment in Oura, enhancing their partnership to integrate continuous glucose monitoring with Oura's health-tracking ring. This collaboration will enable users to access comprehensive data on glucose levels, sleep, and heart health through both Dexcom and Oura apps. As Oura's valuation surpasses $5 billion, this integration aims to empower users to make informed health decisions based on personalized insights. The launch is anticipated in early 2025, marking a significant step in metabolic health management. #HealthcareIT #WearableTech #DigitalHealth #GlucoseMonitoring #MetabolicHealth #HealthTech #Innovation ai.mediformatica.com #oura #health #dexcom #ring #glucose #data #partners #monitoring #partnership #glucosemonitor #ouraring #continuousglucosemonitor #digitalhealth #healthit #healthtech #healthcaretechnology @MediFormatica (https://buff.ly/3CGuXFB)

🤝 ŌURA, the company behind the Oura Ring, a smart ring providing personalized health data, insights, and guidance, has announced the acquisition of Finnish personalized metabolic health company, Veri. Veri, which partners with continuous glucose monitors (CGM) to guide users toward healthier habits, will bring its expertise in metabolic health to ŌURA. 💬 "Metabolic health is the natural next dimension of the Oura Ring holistic health experience, and one that our customers have told us they want. ŌURA started in sleep and has always had a vision of expanding to support all aspects of health. Over time, we’ve built out our offerings across key behaviors like activity and added new health pillars like cardiovascular health, stress & resilience, and women’s health. Metabolic health is an important next horizon and the team at Veri brings deep experience in that space." Tom Hale, OURA CEO #health #healthcare #healthcareinnovation #ecosystem #wearables #healthtech #digitalhealth #metabolichealth #holistichealth #partnership #acquisition

The global Finger Clip Oximeter market was valued at US$ 3781 million in 2023 and is anticipated to reach US$ 5036.8 million by 2030 witnessing a CAGR of 4.2% during the forecast period 20242030. #FingerClipOximeter #HealthMonitoring #MedicalDevices #RespiratoryHealth #HospitalCare #AmbulatorySurgicalCenters #HomeCare #NonInvasive #HealthcareInnovation #GlobalMarket

💡Managing disruptive innovation: How lifestyle gyms are embracing #Ozempic - and what other industries can learn from that. 📈 The GLP-1 drug market around Ozempic and others is expected to grow to $71B by 2032. While this creates value for many players in the market, it is at the same time disrupting existing industries. From food to fitness, many industries are on the edge about being disrupted (or at least significantly changed) by a product that helps users to lose 15-20% of their body weight. But lifestyle gyms like Equinox, Life Time Inc. and Xponential Fitness are in fact embracing the new market, launching programs to cater to people who are on GLP-1. Programs include holistic mobility and nutrition training. Life Time Fitness debuted its #MIORA Longevity and Performance program, including blood test and personalized health recommendations around exercise, nutrition advice, hormone therapy and prescriptions for GLP-1 agonists. The underlying rationale: weight loss drug users are indeed cutting spending on restaurants, but in fact are more active in getting into better physical shape than before. This creates a striking example on how to manage disruptive innovation. Here are 5 take-aways what other industries can learn from that: 1 / #Understand and cater to the underlying consumer motivation - and don't compete with a new solution to it (e.g. weight loss consumers want MORE not LESS physical activity) 2 / #Cater to consumer motivations holistically to unlock new revenue pools (e.g. beyond physical to mental fitness) 3 / #Leverage the power of data and digital services for increasingly personalized offerings 4 / #Partner, partner, partner - to strengthen your value delivery network (e.g. gyms acquiring weight loss clinics) Bloom Partners is helping clients across industries to drive disruption rather than getting disrupted. From helping a global F&B leader to unlock growth from delivery services, to embracing digital health for drug-focused therapies. Driving disruption for a better tomorrow for all of us. Read more on lifestyle gyms and their approach to Ozempic on Quartz: https://lnkd.in/dkwpeBVS Novo Nordisk | Eli Lilly and Company

🗞 NEWS FLASH: Dexcom invests $75M in ŌURA, valuing the company at $5B+ 🤝 Following the recent acquisition of Veri (a Finnish CMG service provider), Oura now announces a strategic partnership with Dexcom (CGM device maker) that includes investment and an integration to allow data to flow between apps in order better understand the link between activity, sleep, nutrition, and their glucose. I have been using the Abbott Lingo for the past few months and can attest to the value of having real time information about how what you eat impacts spikes in glucose. It’s been fun experimenting to optimize my nutrition. It also syncs with my fitness data which also allows me to easily track and see how a walk after eating or an exercise session impact results. This is part of a push by Oura to use strategic partnerships that combine medical-grade technology with advanced software to drive forward the consumerization of healthcare. ⌚ + 🏥 This is well aligned to our vision of the convergence of consumer wearable and medical devices that provide consumer convenience with clinical grade health insights that support continuous, proactive and preventative health. #ConsumerizationofHealth #PreventativeHealth #digitalhealth #CGM #smartrings #partnership

Here at Feel Electric we feel we have a responsibility, not just to provide the best possible service to our members, but to educate, as much as we can, on aspects of health and fitness that are not understood very well. We've already done work on understanding BMI measurements and why they're outdated, now our team tackle the often misunderstood and not particularly well known malady, Fibromyalgia. Fibromyalgia is, as far as medical science understands, incurable, but symptoms of it can be managed with effective treatments. Find out more about Fibromyalgia and possible treatment methods in our blog post below: https://lnkd.in/gn4gGrGH Book a free trial with Feel Electric to experience the ways in which our technology can support those suffering with Fibromyalgia and a host of other benefits. Find out more and book here: https://lnkd.in/ebWiAYqi